CD24 and cancer: Indeed, ex vivo, these peptides were not toxic to lymphocytes derived from healthy volunteers; (b) the target (CD24) is expressed almost exclusively in cancer cells; (c) the lentiviral vectors are self-inactivating and were shown to exert no genotoxicity in 43 gene therapy studies [25].